Orbimed Advisors - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$6,135,648
-2.5%
164,627
+209.4%
0.12%
+48.1%
Q4 2021$6,290,000
-11.9%
53,2000.0%0.08%
+3.8%
Q3 2021$7,137,000
+22.7%
53,200
-26.6%
0.08%
+44.4%
Q1 2021$5,818,000
+101.9%
72,500
-47.1%
0.05%
+31.7%
Q2 2020$2,882,000
-10.1%
137,100
-47.7%
0.04%
-24.1%
Q1 2020$3,205,000
-16.6%
262,1000.0%0.05%
-1.8%
Q4 2019$3,845,000
-12.1%
262,100
-20.0%
0.06%
-33.7%
Q3 2019$4,373,000
-18.5%
327,6000.0%0.08%0.0%
Q2 2019$5,363,000
-16.8%
327,600
-13.2%
0.08%
-17.0%
Q1 2019$6,449,000
+25.1%
377,6000.0%0.10%
+5.3%
Q4 2018$5,154,000
-75.8%
377,600
-49.3%
0.10%
-63.0%
Q3 2018$21,310,000
-11.1%
744,600
-15.0%
0.26%
-10.1%
Q2 2018$23,967,000
+2.1%
876,000
-21.3%
0.29%
-1.7%
Q1 2018$23,473,000
-47.8%
1,113,000
-52.4%
0.29%
-48.8%
Q4 2017$44,930,000
-32.1%
2,337,684
-12.2%
0.57%
-10.1%
Q3 2017$66,155,000
+55.3%
2,662,1800.0%0.63%
+41.7%
Q2 2017$42,595,000
+13.6%
2,662,1800.0%0.45%
+4.9%
Q1 2017$37,510,000
+7.5%
2,662,1800.0%0.42%
-4.5%
Q4 2016$34,901,000
-23.0%
2,662,1800.0%0.44%
-13.8%
Q3 2016$45,310,000
-20.3%
2,662,1800.0%0.52%
-13.0%
Q2 2016$56,838,0002,662,1800.59%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders